EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)

7.18
Delayed Data
As of Oct 04
 +0.07 / +0.98%
Today’s Change
6.91
Today|||52-Week Range
21.50
-41.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$269.5M

Company Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Contact Information

EyePoint Pharmaceuticals, Inc.
480 Pleasant Street
Watertown Massachusetts 02472
P:(617) 926-5000
Investor Relations:

Employees

Shareholders

Individual stakeholders9.50%
Other institutional47.48%
Mutual fund holders26.96%

Top Executives

Nancy Sue LurkerPresident, Chief Executive Officer & Director
Jay S. DukerChief Operating Officer
George O. ElstonCFO & Head-Corporate Development
Dario A. PaggiarinoChief Medical Officer & Senior Vice President
Said SaimChief Technology Officer